Evolus (EOLS) Misses Q2 EPS by 17c

Evolus (NASDAQ: EOLS) reported Q2 EPS of ($0.27), $0.17 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $69.4 million versus the consensus estimate of $82.18 million.

For earnings history and earnings-related data on Evolus (EOLS) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Enanta Pharma loses appeal in Pfizer Paxlovid patent case
• Alphabet to replace Verizon in the Dow Jones Industrial Average